Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of HMGB1-mediated inflammation

Treatment of HMGB1-mediated inflammation

US Patent 10857197 · Granted Dec 8, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Muscarinic acetylcholine receptor subtype 4 antagonists in the treatment of anem2025
Tetranectin-targeting monoclonal antibodies to fight against lethal sepsis and o2025
Nerve stimulation for treatment of diseases and disorders2025
Compounds for use in synthesis of peptidomimetics2025
Choline acetyltransferase as a therapy for hypertension2024
Methods and apparatuses for reducing bleeding via electrical trigeminal nerve st2024
Pet collar2024
HMGB1 antagonist treatment of severe sepsis2024
Systems and methods for real-time monitoring of physiological biomarkers through2024
Treatment of inflammation by selective DMV cholinergic neuron stimulation2023
EpCAM antibody and CAR-T cells2023
HMGB1 antagonist treatment of acute lung injury2023